Reading Room Production — page 207

afety or ure of the active at we are doing will be of itive to maintain to be fungible i's goal it how what we maceutical he'll be to be BY v ne a few > failing or dying on the vine for reasons other than lack of safety or efficacy. The overarching goal of MCMI is to change the nature of the > public-private partnership governing product development efforts in this area, changing the role of government from one of "funder" to active > strategic collaboration. This is where I think what we are doing will be of interest to you: we are using the national security imperative to maintain > focus and drive budgets but adopting an approach which ought to be fungible to other areas where our translational efforts are faltering. Heidi's goal > won't be to co-opt CAN but to think strategically with you about how what we are doing might serve to enhance our drug development efforts more broadly > (and hopefully preserve the competitiveness of the US biopharmaceutical industry in the process). > Happy to chat further but I think that's the kernel of what she'll be > interested in discussing with you. > Do you have a brief bio you could send over by any chance? > Best regards, and I look forward to meeting you on Monday - Richard > Best, > Richard > ------ Forwarded Message From: "Ranganathan, Rajesh (NIH/OD) [C]" @nih.gov > Date: Wed, 17 Nov 2010 20:50:57 -0500 To: "Hatchett, Richard J." @nss.eop.gov > Subject: Re: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative (MCMI) > Richard: > Can you give me some background on what Ms. Avery is likely to be interested > in hearing about. Is there anything I should know about MCMI to be appropriately prepared? > On 11/17/10 5:55 PM, "Hatchett, Richard J." > < @nss.eop.gov> wrote: >> Cyndi, Rajesh -- >> Thanks for being flexible. Ms. Avery was very interested in joining the discussion. We'll meet in her office (EEOB 426) but why don't you come a few >> minutes early and meet me in 421? >> Best, Richard >> -----Original Message----- >> From: Burrus-Shaw, Cyndi (NIH/OD) [E] [mailto @nih.gov] Sent: Wednesday, November 17, 2010 5:50 PM >> To: Hatchett, Richard J. Cc: Ranganathan, Rajesh (NIH/OD) [C] >> Subject: RE: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative (MCMI) >>